Find out the prime time to gulp down those protein shakes and supercharge your muscle growth. Learn how to optimize protein ...

TORL-1-23 Demonstrates Clinically ... in normal tissues, thus an ideal target for antibody-drug conjugate development. CLDN6 ...

--(BUSINESS WIRE)--Septerna, a clinical-stage biotechnology company pioneering a new era of GPCR-targeted drug discovery, today announced the dosing of the first participants in its Phase 1 ...

Discover innovative solutions in advancing protein quality control, optimizing efficiency in high-throughput screening ...

In May 2024, Kura Oncology announced completion of enrollment in the Phase 2 portion of KOMET-001, a registration-directed trial of ziftomenib in patients with R/R NPM1-mutant AML. Enrollment of ...

Does creatine cause hair loss? If you’re worried that creatine supplements might cause baldness, check out the scientific ...

(RTTNews) - Lexeo Therapeutics, Inc. (LXEO) Wednesday reported positive interim results from the Phase 1/2 study of its gene therapy candidate LX1001 for the treatment of APOE4-associated Alzheimer's ...

Good day and welcome to the AGCO third-quarter 2024 earnings call. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Greg Peterson, ...

Mace, the company behind London's famous Shard building and Battersea Power Station, have been assigned the task of building phase 1 of the extension by Dubai World Trade Centre (DWTC).

Positive results for Intellia Therapeutics, Inc.'s NTLA-2002 in treating HAE patients. Stock price dips, but the program ...

Data from the AscenD-LB Phase 2a trial in DLB confirm recent scientific literature indicating that plasma glial fibrillary acid protein (GFAP) is ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines, has presented positive clinical safety and immunogenicity data from a clinical phase 1 study of ...